AI GxP validation for regulated life sciences
Resources

News, Insights And More

Frameworks, checklists and playbooks — the operating knowledge behind our products and services. Practical, not academic.

Quick chat on WhatsAppFree to read in fullNo form to read anything
In short

Cybroscape publishes checklists, frameworks, templates, playbooks, guides and whitepapers for GxP validation, data integrity, audit readiness and AI assurance. All of it is on the page in full rather than behind a form — the checklists additionally offer a spreadsheet working copy with columns for applicability, owner, evidence location and status.

Start here

Which kind of resource you want

A checklist tells you what has to exist and what each item must demonstrate. A framework tells you how to decide — risk level, assurance activity, who approves and what the rationale has to show. A template gives you a document structure to start from. A playbook sequences the work and states what must be true before the next step.

A guide explains a regulation clause by clause in the terms of the work it governs. A whitepaper argues a position and shows the reasoning, for the conversation where someone has to be persuaded.

Library

Every resource

FrameworkCSA Framework — from paper to practiceThe end-to-end Computer Software Assurance operating model — risk profiling, test-strategy selection, vendor-evidence leverage, and audit posture.ChecklistCSV Validation Checklist — the 26-deliverable master listThe full controlled deliverable set for GAMP 5 Second Edition CSV — with applicability by GAMP category and CSA rigor selectors.ChecklistFDA 21 CFR Part 11 Compliance ChecklistPractical Part 11 checklist covering electronic records, electronic signatures, audit trails, and controls.FrameworkAI Validation Framework — Annex 22 alignedHow to validate AI systems used in GxP-regulated processes: model card, eval set, deterministic guardrails, HITL policy, drift, fallback.FrameworkAI Governance Framework for Life SciencesPolicies, model registry, use-case intake, risk classification, red-teaming and drift — designed for regulated environments.PlaybookGAMP 5 Second Edition PlaybookGAMP 5 Second Edition — Agile, critical thinking, CSA alignment — translated into the actual document set, test strategy and roles for your systems.TemplateIQ / OQ / PQ Protocol TemplatesBattle-tested IQ, OQ and PQ protocol templates — configurable to your system class and CSA risk.FrameworkAudit Readiness FrameworkRepeatable audit readiness across GxP systems — mock inspections, evidence-pack drills, RTM sanity, Part 11 posture.GuideEU Annex 11 & Annex 22 Guide (with revision preview)What Annex 11 requires today, what the revision changes, and how Annex 22 (AI in GMP) reshapes the assurance stack.GuideData Integrity (ALCOA+) GuideALCOA+ across GxP systems — with gap assessments, remediation patterns and a monitoring cadence that keeps it from drifting.WhitepaperThe AI-Native Validation Playbook 2026 — a Whitepaper for Life Sciences LeadersWhy the next generation of Life Sciences validation is AI-native and CSA-first — the operating model, the assurance stack, the economics, and how to phase the shift without breaking Part 11 posture.WhitepaperAI-Assisted Clinical Documentation — a Buyer's Guide for CROs and SponsorsHow to evaluate AI-assisted clinical writing platforms for CSR, protocol, safety-narrative, IB, DSUR and CER work — with the eight sponsor questions and the twelve buyer criteria that separate serious tools from demo-ware.WhitepaperEU Annex 22 Readiness — a Whitepaper on AI in GMPWhat EU Annex 22 will require of AI systems used in GMP-regulated processes — a working readiness framework, control-by-control gap assessment, and the assurance evidence regulators will look for.WhitepaperThe Mid-Market Validation Gap — an Economic WhitepaperWhy legacy validation suites cannot serve Series A–C biotech, med-device startups, CDMOs and digital-health scale-ups — and what the mid-market operating model actually looks like when engineered for velocity plus compliance.WhitepaperTransitioning to Computer Software Assurance — a Whitepaper for QA LeadersThe end-to-end CSA transition roadmap — from operating-model change and role redefinition to per-requirement risk, defensible reduction of scripted testing, and audit-ready evidence in the new world.

Why none of it is gated

A checklist nobody can read is not much use to anyone. Putting it behind a form would also hide it from the search and answer engines we publish it to reach, which is most of the point. The content stays free; the form beside a checklist offers the spreadsheet working copy, which is worth an email address precisely because the substance is already available.

How current this is

FDA's Computer Software Assurance guidance was finalised in September 2025 and reissued in February 2026 and is treated as final throughout. The EU GMP Annex 11 revision and the new Annex 22 on artificial intelligence went to consultation in 2025 and have not been adopted — they are cited as drafts every time they appear. These are working aids, not regulatory documents, and they do not replace your own quality system procedures.

Turn the reading into a plan.

Book a demo, or ask a validation lead a quick question on WhatsApp.

  • We reply within one business day
  • We run your URS live on the call
  • You get a clear plan for your system
Chat on WhatsApp

Book a demo

Four fields. The right specialist replies within one business day.

Your details stay private. We never share them.